Skip to main content

Table 3 Percentage of scenarios in which a subgroup might be worse off at different levels of baseline screening uptake

From: Human papilloma virus vaccination programs reduce health inequity in most scenarios: a simulation study

S

δS

Percentage of Scenarios

E = 60%

E = 90%

δE≠0

δE=0

δE≠0

δE=0

20

−0.6

19.41

17.95

23.08

23.08

 

−0.4

16.12

15.38

19.05

17.97

 

−0.2

13.92

12.82

15.75

12.82

 

0

11.36

10.27

10.99

10.26

 

0.2

9.89

10.26

9.52

7.69

 

0.4

7.69

7.69

6.96

5.13

 

0.6

6.28

5.13

5.49

0

50

−0.6

29.67

28.21

41.39

43.59

 

−0.4

24.54

25.64

32.60

33.33

 

−0.2

17.95

17.95

22.71

25.64

 

0

12.45

10.26

16.11

10.26

 

0.2

9.89

5.13

11.72

0

 

0.4

7.33

0

10.25

0

 

0.6

5.86

0

7.91

0

70

−0.6

38.83

41.03

56.41

58.97

 

−0.4

30.77

30.77

44.69

48.72

 

−0.2

21.61

23.08

30.77

35.90

 

0

15.02

10.26

24.59

10.26

 

0.2

10.98

0

20.46

0

 

0.4

8.42

0

16.67

0

 

0.6

6.97

0

15.92

0

90

−0.6

49.08

48.72

75.46

76.92

 

−0.4

37.73

41.03

62.27

66.67

 

−0.2

26.01

28.21

47.95

53.85

 

0

18.32

10.26

37.67

10.26

 

0.2

15.16

0

33.87

0

 

0.4

12.56

0

30.57

0

 

0.6

11.83

0

32.03

0

  1. S = Screening uptake.
  2. E = Baseline screening sensitivity (the sensitivity of the test).
  3. δS =Proportional change in screening uptake.
  4. δE = Proportional change in screening sensitivity.
  5. Coverage and vaccine effectiveness are set at 90%, baseline sensitivity is set at 60% and 90%.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us